Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:tobacco
|
| gptkbp:advertising |
focused on health benefits
emphasize support resources targeted at smokers |
| gptkbp:approves |
gptkb:1984
|
| gptkbp:associated_with |
gptkb:psychotherapy
support groups quit smoking programs |
| gptkbp:available_in |
various flavors
|
| gptkbp:clinical_trial |
conducted for safety
conducted for efficacy |
| gptkbp:contraindication |
pregnancy
breastfeeding hypersensitivity to nicotine |
| gptkbp:dosage_form |
gptkb:candy
gptkb:patches varies by product oral lozenge |
| gptkbp:formulation |
gptkb:Loewe
gptkb:candy gptkb:patches |
| https://www.w3.org/2000/01/rdf-schema#label |
Nicorette
|
| gptkbp:ingredients |
nicotine
|
| gptkbp:manufacturer |
gptkb:Johnson_&_Johnson
|
| gptkbp:marketed_as |
gptkb:tobacco
|
| gptkbp:packaging |
over-the-counter
prescription required in some countries |
| gptkbp:part_of |
public health initiatives
tobacco control efforts smoking cessation strategy |
| gptkbp:price_range |
varies by product and location
|
| gptkbp:regulatory_compliance |
approved by FDA
approved by European Medicines Agency approved by Health Canada |
| gptkbp:release_region |
gptkb:Australia
gptkb:Canada gptkb:Germany gptkb:United_Kingdom gptkb:United_States |
| gptkbp:research |
ongoing for long-term effects
ongoing for combination therapies ongoing for user adherence |
| gptkbp:side_effect |
dizziness
headache nausea insomnia mouth irritation |
| gptkbp:success_rate |
varies by individual
higher with support improved with behavioral therapy |
| gptkbp:used_for |
smoking cessation
|
| gptkbp:user_reviews |
generally positive
some report side effects effective for many users |
| gptkbp:bfsParent |
gptkb:Pfizer_Consumer_Healthcare
gptkb:Haleon |
| gptkbp:bfsLayer |
5
|